The proposed volume attempts to understand how forms of bio-innovation might be linked to the problem of poverty and its reduction through an inquiry into a number of empirical cases of present-day bio-innovations in Asia. Conditions and circumstances in countries like Cambodia, China, India, Korea, Nepal, Philippines, and Thailand are quite different and provide a mosaic of varied experiences in bio-innovation that include shrimp farming, GMO cotton, bio gas, organic farming, and vaccines.
Offering important insights into various forms of bio-innovation efforts and their effects on poverty alleviation, this volume is divided into three major themes that organize the main sections of the book—benefits for the poor: actual, direct, and prospective benefits for the poor; absence of positive impacts and institutional constraints; pro-poor drivers and embedding in anti-poverty alleviation.
The central questions addressed here are: Ways and circumstances in which certain forms of bio-innovations affect the poor and enable poverty alleviation.; Critical factors and conditions for improving the positive impact of bio-innovations on poverty alleviation.; Poverty alleviation goals should be the point of departure in rationalizing, identifying and designing appropriate and relevant bio-innovation programs.
Chapter 8: Vaccine R&D in Thailand: Meeting Public Health Needs Through Collective IPR Management
Vaccine R&D in Thailand: Meeting Public Health Needs Through Collective IPR Management
During the 2003 outbreak of severe acute respiratory syndrome (SARS), researchers collaborated in a global effort to identify the SARS virus to help contain it. Although successful in rapidly identifying and sequencing the SARS coronavirus genome, the collaboration attracted controversy when it became known that the collaborating research institutions had filed applications claiming patent rights over the sequenced genome. While proponents argued that the patent applications constituted a pre-emptive and defensive strategy aimed at preserving the space for continued scientific research, there was concern that such patenting could risk hampering not only the research process but also access to future products, such ...